Table 3 from Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal Cancer

Outpatient pharmacy prescription charges and OOP expenses between patients with mCRC and non-mCRC(in $2023).转移性结直肠癌（metastatic colorectal cancer, mCRC）患者与非转移性结直肠癌（non-metastatic colorectal cancer, non-mCRC）患者的门诊药房处方费用及自付费用（out-of-pocket expenses, OOP），以2023年美元计价。